Cleared Traditional

K152301 - Background Pattern Classification [BPc(TM)]

K152301 is an FDA 510(k) clearance for Background Pattern Classification [BPc(TM)], manufactured by Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek). The device is a Class 2 Neurology device with product code OMA cleared through the Traditional 510(k) pathway after a 294-day FDA review.

K152301 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
294d
Days
Class 2
Risk

K152301 is an FDA 510(k) clearance for the Background Pattern Classification [BPc(TM)]. Classified as Amplitude-integrated Electroencephalograph (product code OMA), Class II - Special Controls.

Submitted by Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) (Oakville, CA). The FDA issued a Cleared decision on June 3, 2016 after a review of 294 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) devices

FDA 510(k) Submission Details - K152301

510(k) Number K152301 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2015
Decision Date June 03, 2016
Days to Decision 294 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
146d slower than avg
Panel avg: 148d · This submission: 294d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OMA Device Classification - Class 2, Special Controls

Product Code OMA Amplitude-integrated Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - OMA Amplitude-integrated Electroencephalograph

Devices cleared under the same product code (OMA) and FDA review panel - the closest regulatory comparables to K152301.
Neo
K192889 · Eemagine Medical Imaging Solutions GmbH · Jan 2020
NIHON KOHDEN QP-160 AK TREND PROGRAM WITH THE ADDITION OF DSA ASYMMETRY TREND AND FFT P
K120485 · Nihon Kohden America, Inc. · Mar 2012
NIHON KOHDEN QP-160AK EEG TREND PROGRAM
K092573 · Nihon Kohden America, Inc. · Jul 2010
OLYMPIC CFM 6000
K031149 · Olympic Medical Corp. · May 2003
OLYMPIC MEDICAL LECTROMED CEREBRAL FUNCTION MONITOR SYSTEM
K983229 · Olympic Medical Corp. · Mar 1999